Patients  ||| S:0 E:9 ||| NNS
with  ||| S:9 E:14 ||| IN
oral  ||| S:14 E:19 ||| JJ
allergic  ||| S:19 E:28 ||| JJ
syndrome  ||| S:28 E:37 ||| NN
to  ||| S:37 E:40 ||| TO
apple  ||| S:40 E:46 ||| NN
have  ||| S:46 E:51 ||| VBP
intense  ||| S:51 E:59 ||| JJ
proliferative  ||| S:59 E:73 ||| JJ
response  ||| S:73 E:82 ||| NN
to  ||| S:82 E:85 ||| TO
BET  ||| S:85 E:89 ||| NNP
V  ||| S:89 E:91 ||| NNP
1  ||| S:91 E:93 ||| CD
Patients  ||| S:93 E:102 ||| NNS
with  ||| S:102 E:107 ||| IN
pollen  ||| S:107 E:114 ||| JJ
allergy  ||| S:114 E:122 ||| NN
may  ||| S:122 E:126 ||| MD
frequently  ||| S:126 E:137 ||| RB
present  ||| S:137 E:145 ||| VB
an  ||| S:145 E:148 ||| DT
additional  ||| S:148 E:159 ||| JJ
food-related  ||| S:159 E:172 ||| JJ
allergy  ||| S:172 E:180 ||| NN
( ||| S:180 E:181 ||| -LRB-
Oral  ||| S:181 E:186 ||| NNP
Allergic  ||| S:186 E:195 ||| NNP
Syndrome ||| S:195 E:203 ||| NNP
,  ||| S:203 E:205 ||| ,
OAS ||| S:205 E:208 ||| NNP
) ||| S:208 E:209 ||| -RRB-
,  ||| S:209 E:211 ||| ,
as  ||| S:211 E:214 ||| IN
consequence  ||| S:214 E:226 ||| NN
of  ||| S:226 E:229 ||| IN
cross-reactivity  ||| S:229 E:246 ||| JJ
between  ||| S:246 E:254 ||| IN
pollen  ||| S:254 E:261 ||| NN
allergens  ||| S:261 E:271 ||| NNS
( ||| S:271 E:272 ||| -LRB-
mainly  ||| S:272 E:279 ||| RB
birch ||| S:279 E:284 ||| JJ
,  ||| S:284 E:286 ||| ,
hazelnut ||| S:286 E:294 ||| NN
,  ||| S:294 E:296 ||| ,
alder ||| S:296 E:301 ||| NN
,  ||| S:301 E:303 ||| ,
mugwort ||| S:303 E:310 ||| CD
)  ||| S:310 E:312 ||| -RRB-
and  ||| S:312 E:316 ||| CC
vegetable  ||| S:316 E:326 ||| JJ
allergens ||| S:326 E:335 ||| NN
.  ||| S:335 E:337 ||| .
The  ||| S:337 E:341 ||| DT
aim  ||| S:341 E:345 ||| NN
of  ||| S:345 E:348 ||| IN
this  ||| S:348 E:353 ||| DT
study  ||| S:353 E:359 ||| NN
was  ||| S:359 E:363 ||| VBD
to  ||| S:363 E:366 ||| TO
evaluate  ||| S:366 E:375 ||| VB
the  ||| S:375 E:379 ||| DT
effect  ||| S:379 E:386 ||| NN
on  ||| S:386 E:389 ||| IN
Bet  ||| S:389 E:393 ||| NNP
v  ||| S:393 E:395 ||| VBD
1-induced  ||| S:395 E:405 ||| CD
T  ||| S:405 E:407 ||| NN
cell  ||| S:407 E:412 ||| NN
proliferation  ||| S:412 E:426 ||| NN
exerted  ||| S:426 E:434 ||| NN
by  ||| S:434 E:437 ||| IN
the  ||| S:437 E:441 ||| DT
presence  ||| S:441 E:450 ||| NN
of  ||| S:450 E:453 ||| IN
OAS  ||| S:453 E:457 ||| NNP
in  ||| S:457 E:460 ||| IN
birch  ||| S:460 E:466 ||| JJ
patients ||| S:466 E:474 ||| NNS
.  ||| S:474 E:476 ||| .
Fourteen  ||| S:476 E:485 ||| JJ
allergic  ||| S:485 E:494 ||| JJ
patients  ||| S:494 E:503 ||| NNS
were  ||| S:503 E:508 ||| VBD
evaluated  ||| S:508 E:518 ||| VBN
( ||| S:518 E:519 ||| -LRB-
6  ||| S:519 E:521 ||| CD
males ||| S:521 E:526 ||| NNS
,  ||| S:526 E:528 ||| ,
mean  ||| S:528 E:533 ||| JJ
age  ||| S:533 E:537 ||| NN
35.8  ||| S:537 E:542 ||| CD
years ||| S:542 E:547 ||| NNS
) ||| S:547 E:548 ||| -RRB-
.  ||| S:548 E:550 ||| .
All  ||| S:550 E:554 ||| DT
of  ||| S:554 E:557 ||| IN
them  ||| S:557 E:562 ||| PRP
were  ||| S:562 E:567 ||| VBD
monosensitized  ||| S:567 E:582 ||| VBN
to  ||| S:582 E:585 ||| TO
birch  ||| S:585 E:591 ||| VB
and  ||| S:591 E:595 ||| CC
suffered  ||| S:595 E:604 ||| VBN
from  ||| S:604 E:609 ||| IN
allergic  ||| S:609 E:618 ||| JJ
rhinitis ||| S:618 E:626 ||| NN
:  ||| S:626 E:628 ||| :
4  ||| S:628 E:630 ||| CD
had  ||| S:630 E:634 ||| VBD
also  ||| S:634 E:639 ||| RB
OAS  ||| S:639 E:643 ||| NNP
to  ||| S:643 E:646 ||| TO
apple ||| S:646 E:651 ||| NN
.  ||| S:651 E:653 ||| .
Proliferation  ||| S:653 E:667 ||| NN
of  ||| S:667 E:670 ||| IN
peripheral  ||| S:670 E:681 ||| JJ
mononuclear  ||| S:681 E:693 ||| JJ
cells  ||| S:693 E:699 ||| NNS
was  ||| S:699 E:703 ||| VBD
evaluated  ||| S:703 E:713 ||| VBN
using  ||| S:713 E:719 ||| VBG
Bet  ||| S:719 E:723 ||| NNP
v  ||| S:723 E:725 ||| VBD
1  ||| S:725 E:727 ||| CD
and  ||| S:727 E:731 ||| CC
non-specific  ||| S:731 E:744 ||| JJ
stimuli ||| S:744 E:751 ||| NNS
.  ||| S:751 E:753 ||| .
OAS  ||| S:753 E:757 ||| NNP
had  ||| S:757 E:761 ||| VBD
higher  ||| S:761 E:768 ||| JJR
proliferation  ||| S:768 E:782 ||| NN
than  ||| S:782 E:787 ||| IN
non-OAS  ||| S:787 E:795 ||| JJ
patients ||| S:795 E:803 ||| NNS
.  ||| S:803 E:805 ||| .
In  ||| S:805 E:808 ||| IN
addition ||| S:808 E:816 ||| NN
,  ||| S:816 E:818 ||| ,
there  ||| S:818 E:824 ||| EX
were  ||| S:824 E:829 ||| VBD
significant  ||| S:829 E:841 ||| JJ
relationships  ||| S:841 E:855 ||| NNS
between  ||| S:855 E:863 ||| IN
immunological  ||| S:863 E:877 ||| NN
and  ||| S:877 E:881 ||| CC
clinical  ||| S:881 E:890 ||| JJ
parameters  ||| S:890 E:901 ||| NNS
in  ||| S:901 E:904 ||| IN
OAS  ||| S:904 E:908 ||| NNP
patients ||| S:908 E:916 ||| NNS
.  ||| S:916 E:918 ||| .
This  ||| S:918 E:923 ||| DT
study  ||| S:923 E:929 ||| NN
evidences  ||| S:929 E:939 ||| NN
that  ||| S:939 E:944 ||| IN
OAS  ||| S:944 E:948 ||| NNP
characterizes  ||| S:948 E:962 ||| VBZ
a  ||| S:962 E:964 ||| DT
more  ||| S:964 E:969 ||| RBR
severe  ||| S:969 E:976 ||| JJ
form  ||| S:976 E:981 ||| NN
of  ||| S:981 E:984 ||| IN
birch  ||| S:984 E:990 ||| JJ
allergy ||| S:990 E:997 ||| NN
:  ||| S:997 E:999 ||| :
as  ||| S:999 E:1002 ||| IN
OAS  ||| S:1002 E:1006 ||| NNP
patients  ||| S:1006 E:1015 ||| NNS
had  ||| S:1015 E:1019 ||| VBD
higher  ||| S:1019 E:1026 ||| JJR
SI ||| S:1026 E:1028 ||| NNP
,  ||| S:1028 E:1030 ||| ,
circulating  ||| S:1030 E:1042 ||| VBG
eosinophils ||| S:1042 E:1053 ||| NN
,  ||| S:1053 E:1055 ||| ,
and  ||| S:1055 E:1059 ||| CC
IgE  ||| S:1059 E:1063 ||| JJ
levels ||| S:1063 E:1069 ||| NNS
.  ||| S:1069 E:1071 ||| .
Thus ||| S:1071 E:1075 ||| RB
,  ||| S:1075 E:1077 ||| ,
this  ||| S:1077 E:1082 ||| DT
study  ||| S:1082 E:1088 ||| NN
confirms  ||| S:1088 E:1097 ||| VBZ
the  ||| S:1097 E:1101 ||| DT
previous  ||| S:1101 E:1110 ||| JJ
report  ||| S:1110 E:1117 ||| NN
and  ||| S:1117 E:1121 ||| CC
underlines  ||| S:1121 E:1132 ||| VBG
the  ||| S:1132 E:1136 ||| DT
relevance  ||| S:1136 E:1146 ||| NN
of  ||| S:1146 E:1149 ||| IN
measuring  ||| S:1149 E:1159 ||| VBG
recombinant  ||| S:1159 E:1171 ||| JJ
birch  ||| S:1171 E:1177 ||| JJ
allergen  ||| S:1177 E:1186 ||| NN
as  ||| S:1186 E:1189 ||| IN
higher  ||| S:1189 E:1196 ||| JJR
values  ||| S:1196 E:1203 ||| NNS
may  ||| S:1203 E:1207 ||| MD
suggest  ||| S:1207 E:1215 ||| VB
a  ||| S:1215 E:1217 ||| DT
reliable  ||| S:1217 E:1226 ||| JJ
prediction  ||| S:1226 E:1237 ||| NN
of  ||| S:1237 E:1240 ||| IN
OAS ||| S:1240 E:1243 ||| NNP
.  ||| S:1243 E:1245 ||| .
